Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 15: 295-306, 1969;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amenta, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amenta, J. S.

Clinical Chemistry, Vol 15, 295-306, Copyright © 1969 by the American Association for Clinical Chemistry

Lipiodol Absorption and Urinary Iodide Excretion as a Screening Test for Steatorrhea

Joseph S. Amenta 1

1 Clinical Chemistry Laboratory, University Health Center of Pittsburgh, and Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pa. 15213.

The Lipiodol absorption test, quantifying urinary iodide concentration 8-12 hr. after ingestion of Lipiodol, is proposed as an effective screening technic for lipid malabsorption. Urinary iodide is converted to free iodine with nitrous acid; the free iodine is extracted into chloroform, producing a characteristic pink color which is quantified photometrically. Under the dosage conditions used, a urinary iodide concentration of less than 0.4 mM/L strongly suggests abnormal absorption of fat. The results of this test have been correlated with fat balance studies in 12 patients with symptoms of intestinal disease and 12 patients asymptomatic for intestinal disease. The screening test was abnormal in all 7 patients with abnormal fat balance studies and in 2 patients with normal fat balance studies. The remaining 15 patients had a normal screening test and normal fat balance studies. No false negatives were found. The simplicity of the test, coupled with its high correlation with the fat balance studies, recommend its use in the clinical laboratory as a valid screening procedure in all patients with suspected steatorrhea.

Submitted on May 6, 1968
Accepted on August 13, 1968







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1969 by the American Association for Clinical Chemistry.